洁特生物（688026）8月14日主力资金净流出3352.19万元

Core Points - The stock price of Jiet Biotech (688026) closed at 19.77 yuan, down 5.86% as of August 14, 2025 [1] - The company reported a total revenue of 124 million yuan for Q1 2025, representing a year-on-year growth of 26% [1] - Net profit attributable to shareholders reached 16.46 million yuan, up 101.29% year-on-year [1] - The company has a current ratio of 8.034 and a quick ratio of 6.628, indicating strong liquidity [1] Financial Performance - Total revenue for Q1 2025: 1.24 billion yuan, up 26% year-on-year [1] - Net profit: 16.46 million yuan, up 101.29% year-on-year [1] - Non-recurring net profit: 15.65 million yuan, up 269.23% year-on-year [1] - Asset-liability ratio: 28.76% [1] Company Overview - Jiet Biotech was established in 2001 and is located in Guangzhou [2] - The company focuses on research and experimental development [2] - Registered capital: 1.403 billion yuan, paid-in capital: 40 million yuan [2] - The legal representative is Yuan Jianhua [2] Investment and Intellectual Property - The company has invested in 14 enterprises and participated in 182 bidding projects [2] - It holds 79 trademark registrations and 266 patents [2] - The company has obtained 67 administrative licenses [2]